Stock Price Movement of Virgin Galactic, DoorDash, and more Companies
Share prices for Virgin Galactic have underwent a 4.9% depression in premarket trading. The share costs for the commercial space flight company suffered from a dip after making an announcement about its commercial space flight service.
The space company revealed that it has decided to delay its space flight service until next year. The executives have confirmed that they will be resuming their space flight program somewhere in the first three months of 2022.
The company has attributed the delay in the space flight program to issues related to supply chain and labor. The cash burn levels of Virgin Galactic are also another major factor that has grown a lot of concerns among the analysts.
DoorDash has reportedly underwent a 6% stock price elevation in today’s stock market. The surge is due to the earnings report DoorDash has shared for the first quarter of 2022.
The executives at the food delivery company revealed the revenue they generated was much higher than the estimations made by the analysts at Refinitiv. They also revealed that they have earned an achievement in the first quarter of 2022 as well.
According to the executives, in the first quarter, they recorded more than 400 million orders. This is the first time in the history of DoorDash that such a high benchmark has been achieved.
The stakecosts for Peloton have experienced a 1.8% dip in post-market trading. The share rates for the fitness equipment maker experienced a slope after mentioning a sale of its stake.
The executives revealed that they will be selling a sizable minority stake. The inside sources have revealed that if Peloton executives give the green signal, then 15% to 20% of the minority stake will be sold off.
It is yet to be decided whether the deal will be finalized or not. The inside sources were not able to confirm which entity has shown interest in acquiring a stake in Peloton.
Johnson & Johnson
The trading prices for Johnson & Johnson’s stocks slid by 1% in the premarket trading. Johnson & Johnson’s share prices experienced a dint after the FDA shared an update regarding the vaccine for COVID-19. It was announced by the FDA that with immediate effect, the pharmaceutical companies will need to limit the usage of the COVID-19 vaccine.
The reason why FDA made the decision was due to reporting of cases where the patients injected with the vaccine had blood clots. The decision has been made by FDA only for the vaccine produced by Johnson & Johnson.
According to the FDA officials, the Johnson & Johnson COVID-19 vaccine will be administrated to patients not eligible for any other vaccines for COVID.